Brief: Clinical Laserthermia Systems Q2 Pretax Loss Widens To SEK 12.9 Mln
Aug 26 (Reuters) - Clinical Laserthermia Systems AB
CLSRb.ST :
* Q2 NET SALES SEK 0.3 MILLION VERSUS SEK 0.3 MILLION YEAR
AGO
* Q2 PRETAX LOSS SEK 12.9 MILLION VERSUS LOSS SEK 10.5
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr4gd0nM
Further company coverage: CLSRb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Clinical Laserthermia Systems AB
See all newsBrief: CLS Enters Research Agreement With U.S. National Cancer Institute
Sweden's CLS Q1 sales fall 72% after partner talks
Brief: Clinical Laserthermia Systems Q1 EBIT Sek 1.7 Mln
Brief: CLS Receives Order Worth SEK 23 Mln For Prism Business
Brief: CLS Expects To Achieve Positive Cash Flow From Q4 2026 To Q1 2028